好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Anti- and Pro-inflammatory Milieu Differentially Regulate Differentiation and Immune Functions of Oligodendrocyte Progenitor Cells
Multiple Sclerosis
P5 - Poster Session 5 (8:00 AM-9:00 AM)
1-013

We aimed to examine the effects of pro-inflammatory cytokines, represented by interferon (IFN)-γ and tumor necrosis factor (TNF)-α, as well as anti-inflammatory cytokines, represented by interleukin(IL)-4 and IL-10, on oligodendrocyte progenitor cells (OPC) differentiation and immune characteristics.


OPCs were regarded for years solely for their regenerative role; however, their immune-modulatory roles have gained much attention recently, particularly in the context of multiple sclerosis (MS). Despite extensive studies on OPCs, there are limited data elucidating the interactions between their intrinsic regenerative and immune functions, as well as their relationship with the inflamed central nervous system (CNS) environment, a key factor in MS pathology.


Using primary cultures, ELISA, and immunofluorescence stainings, we assessed differentiation capacity, phagocytic activity, major histocompatibility complex (MHC)-II expression, and cytokine secretion.


We observed that the anti-inflammatory milieu (IL4 and IL10) reduced both OPC differentiation and immune functions. Conversely, exposure to TNF-α led to intact differentiation, increased phagocytic activity, high levels of MHC-II expression, and cytokines secretion. Those effects were attributed to signaling via TNF-receptor-2 (TNFR2) and counteracted the detrimental effects of IFNγ on OPC differentiation.


Our findings suggest that a pro-regenerative, permissive inflammatory environment is needed for OPCs to execute both regenerative and immune-modulatory functions.


Authors/Disclosures
Omri Zveik, MD
PRESENTER
Mr. Zveik has nothing to disclose.
Ariel Rechtman (Hadassah-Hebrew University Medical Center) Ariel Rechtman has nothing to disclose.
Adi Vaknin-Dembinsky, MD No disclosure on file